Losarzen Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Celix Co., Ltd.
MFDS item code 200600367 · Notified 2006.03.31
This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension, and it is particularly helpful in the prevention and treatment of kidney disease in patients with hypertension and type 2 diabetes. It contributes to effectively controlling blood pressure and protecting kidney function.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after initiation of treatment. If the treatment effect is inadequate, the same dose may be given orally in two divided doses daily or, if necessary, the dose may be increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure response. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special patient populations No adjustment of the initial dose is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see the Precautions for Use section). A lower dose should be considered in patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years or older, weighing 20 kg or more but less than 50 kg, who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily according to the patient's blood pressure response. Children and adolescents aged 6 years or older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the 2nd and 3rd trimesters, thus it should not be used by women who are pregnant or may become pregnant. If pregnancy is confirmed, this medication should be discontinued immediately, and regular examinations are necessary to monitor the health status of the fetus. This medication should not be administered to patients with severe liver or kidney impairment, certain genetic diseases, or those with a history of allergic reactions. Elderly patients, those with significantly low blood pressure, high serum potassium levels, or those with heart or vascular diseases should take this medication with caution. Blood pressure and kidney function should be regularly monitored during treatment as there may be risks of excessively low blood pressure or kidney function issues. Drug interactions may occur if combined with other medications, so consultation with a doctor or pharmacist is advised, especially regarding the concurrent use of potassium supplements or potassium-containing medications, which can be dangerous. Rare side effects such as skin rashes, headaches, dizziness, muscle pain, and digestive disorders may occur, and if severe allergic reactions or angioedema happen, intake must be stopped immediately and medical attention sought. If a pregnant woman takes this medication, severe side effects such as low blood pressure or reduced kidney function may occur in the newborn, so close monitoring of the infant's condition is necessary. This medication is not recommended for breastfeeding women, and it is advisable to stop breastfeeding while on this medication. Children, particularly those under 6 years of age or with severe kidney impairment, should not take this medication. In cases of overdose, low blood pressure and heart rhythm abnormalities may occur, so immediate medical attention should be sought if suspected. Dizziness or drowsiness may occur during driving or operating machinery while taking this medication, so caution is needed.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. The storage temperature should ideally be maintained between 1 degree and 30 degrees Celsius at room temperature to preserve its effectiveness.
White oval film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Losartan Potassium 50mg
Tablet · Prescription medication
Celix Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.